Contact
searchSearch
HMP Global
Quiz

Treatment for Nonrad axSpA

Priyam Vora, Associate Editor

12/04/2023
© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Rheumatology and Arthritis Learning Network or HMP Global, their employees, and affiliates. 

Popular Articles

Sponsored Video
Cytokines and the Future of Rheumatology
04/30/2024
In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
In part 1 of this video series, Professor Iain McInnes of the University of Glasgow discusses how advances in molecular medicine have revolutionized the treatment of axial spondyloarthritis.
In part 1 of this video series,...
04/30/2024
Rheumatology & Arthritis
News
Meta-Analysis Finds Robust Evidence Supporting Upadacitinib for axSpA
09/18/2024
Jolynn Tumolo
Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.
Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.
Upadacitinib was associated with...
09/18/2024
Rheumatology & Arthritis
News
Work Productivity Among Patients With PsA Treated With DMARDS
06/19/2024

Jessica Garlewicz, Digital Managing Editor

Jessica Garlewicz, Digital Managing E...
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
The systematic review and meta-analysis demonstrate that PsA substantially reduces work capacity and leisure activity participation but significant improvements are achieved after 24 weeks of treatment.
The systematic review and...
06/19/2024
Rheumatology & Arthritis
News
Disease Burden of Occupations on Patients With PsA
10/18/2024
Jessica Garlewicz
More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.
More study is needed to gain understanding of how physical work may influence disease activity among patients with psoriatic arthritis.
More study is needed to gain...
10/18/2024
Rheumatology & Arthritis
News
Treat-to-Target Approach in RA Found “Suboptimal”
08/14/2024
Rebecca Mashaw
A systematic review sought to identify barriers to implementing treat-to-target in managing rheumatoid arthritis.
A systematic review sought to identify barriers to implementing treat-to-target in managing rheumatoid arthritis.
A systematic review sought to...
08/14/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use